Profile picture

Doctor Ian Menown

Craigavon Cardiac Centre, Craigavon (United Kingdom of Great Britain & Northern Ireland)
Membership: FESC Member
Follow
Biography
Dr Menown MB BCh BAO MD MRCP(UK) FRCP(Edin), is Consultant Cardiologist & Director of Interventional Cardiology at Craigavon Cardiac Centre, Northern Ireland, current President of the Irish Atherosclerosis Society and Honorary Senior Lecturer at Queen's University, Belfast. His special interests include general & acute cardiology, chest pain, coronary artery disease, interventional cardiology (angioplasty/stenting), atrial fibrillation, hypertension (high blood pressure), heart failure, cholesterol management and coronary prevention/screening, and coronary risk reduction. Dr Menown received his medical degree from Queen's University, Belfast with distinction including awards of the Whitla Medal, Musgrave Prize, ARC Prize and Sir John Henry Biggart Medal. He then trained in Cardiology in Belfast before completing an interventional fellowship at Vancouver Hospital & Health Sciences Centre, Canada. He obtained a postgraduate doctorate of medicine, the Purce Medal and JD Williams Prize.
Logo ESC

Contributor content

Clinical outcomes with cobalt chromium biolimus eluting drug-eluting stents compared with stainless steel biolimus eluting drug-eluting stents in all-comers patients
Presentation
Clinical outcomes with cobalt chromium biolimus eluting drug-eluting stents compared with stainless steel biolimus eluting drug-eluting stents in all-comers patients
Clinical outcomes of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention
Presentation
Clinical outcomes of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention
Efficacy and safety of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention
Presentation
Efficacy and safety of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention

ESC 365 is supported by